Oftan Dexa-Chlora (Chloramphenicol, Dexamethasone)

Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, stopping bacterial growth. Dexamethasone activates glucocorticoid receptors, suppressing inflammatory cytokine production and reducing swelling, pain, and cellular infiltration in ocular tissues.

The dosing regimen for Oftan Dexa‑Chlora is determined by the prescribing clinician based on the specific condition, severity, and patient factors. The prescriber will provide instructions on the number of drops, frequency, and duration of therapy.

Safety data for chloramphenicol/dexamethasone in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against possible risks before prescribing to pregnant or nursing women. Consultation with a physician is essential.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Compared with single‑agent eye drops, Oftan Dexa‑Chlora offers both antibacterial and anti‑inflammatory actions in one formulation, reducing the need for multiple products. It is particularly useful when infection and inflammation coexist, whereas alternatives may address only one aspect.

Store the product at room temperature, away from direct sunlight and moisture. Keep it in the original container with the cap tightly closed. Do not freeze or expose to extreme temperatures, and discard any solution that appears discolored or contaminated.

The medication is applied as eye drops. The patient should wash hands, tilt the head back, pull down the lower eyelid to form a pocket, and instill the prescribed number of drops. Close the eye gently for a few seconds and avoid blinking excessively.

Serious risks include corneal ulceration, secondary ocular infection, cataract formation, increased intra‑ocular pressure leading to glaucoma, and rare systemic bone‑marrow suppression from chloramphenicol absorption. Prompt medical attention is required if any severe symptoms develop.

Patients with known hypersensitivity to chloramphenicol, dexamethasone, or any component of the formulation should avoid use. It is also contraindicated in viral eye infections such as herpes simplex keratitis, unless specifically directed by a specialist.